Human cytomegalovirus inhibits apoptosis by regulating the activating transcription factor 5 signaling pathway in human malignant glioma cells

Wang,Tongmei; Qian,Dongmeng; Hu,Ming; Li,Ling; Zhang,Li; Chen,Hao; Yang,Rui; Wang,Bin

doi:10.3892/ol.2014.2264

Human cytomegalovirus inhibits apoptosis by regulating the activating transcription factor 5 signaling pathway in human malignant glioma cells

Authors:
- Tongmei Wang
- Dongmeng Qian
- Ming Hu
- Ling Li
- Li Zhang
- Hao Chen
- Rui Yang
- Bin Wang
View Affiliations

Affiliations: Department of Microbiology, Qingdao University Medical College, Qingdao, Shandong 266071, P.R. China
Published online on: June 18, 2014 https://doi.org/10.3892/ol.2014.2264
Pages: 1051-1057

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The activating transcription factor 5 (ATF5), also termed ATFx, is a member of the ATF/cAMP response element‑binding protein (CREB) family of basic zipper proteins. ATF5 is an anti‑apoptotic protein that is highly expressed in malignant glioma and is essential for glioma cell survival. Accumulating evidence indicates that human malignant gliomas are universally infected with human cytomegalovirus (HCMV). Recent studies have shown that HCMV may be resistant to the induction of apoptosis by disrupting cellular pathways in glioblastoma. To investigate the potential anti‑apoptotic function of HCMV in glioma, malignant U87 glioma cells were infected with HCMV. The present study showed that HCMV infection suppressed apoptosis in glioblastoma U87 cells by regulating the expression of ATF5. Furthermore, in glioblastoma U87 cells, HCMV infection induced cellular proliferation in parallel with an increase in the expression level of ATF5 and B‑cell lymphoma/leukemia‑2 to Bcl‑2‑associated X protein ratio. Loss of ATF5 function was achieved using a dominant‑negative form of ATF5 in U87 cells, whereby cells appeared to grow marginally following HCMV infection when compared with the control. However, the anti‑apoptotic ability was appeared to decline in the terminal deoxynucleotidyl transferase‑mediated dUTP nick end labeling assay. These results indicate that ATF5 signaling pathways may be important in the anti‑apoptotic activity of HCMV‑infected glioblastoma cells; therefore, the anti‑apoptotic molecular mechanisms of HCMV in human glioblastoma cells were investigated in the current study. Prevention of HCMV infection may present a potential and promising approach for the treatment of malignant gliomas.

View Figures

View References

1	Arias A, Lamé MW, Santarelli L, Hen R, Greene LA and Angelastro JM: Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas. Oncogene. 31:739–751. 2012.
2	Stupp R, Mason WP, van den Bent MJ, et al: European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005.
3	Vescovi AL, Galli R and Reynolds BA: Brain tumour stem cells. Nat Rev Cancer. 6:425–436. 2006.
4	Michaelis M, Doerr HW and Cinatl J: The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia. 11:1–9. 2009.
5	Sheng Z, Li L, Zhu LJ, et al: A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications. Nat Med. 16:671–677. 2010.
6	Persengiev SP and Green MR: The role of ATF/CREB family members in cell growth, survival and apoptosis. Apoptosis. 8:225–228. 2003.
7	Watatani Y, Ichikawa K, Nakanishi N, et al: Stress-induced translation of ATF5 mRNA is regulated by the 5′-untranslated region. J Biol Chem. 283:2543–2553. 2008.
8	Angelastro JM, Ignatova TN, Kukekov VG, et al: Regulated expression of ATF5 is required for the progression of neural progenitor cells to neurons. J Neurosci. 23:4590–4600. 2003.
9	Persengiev SP, Devireddy LR and Green MR: Inhibition of apoptosis by ATFx: a novel role for a member of the ATF/CREB family of mammalian bZIP transcription factors. Genes Dev. 16:1806–1814. 2002.
10	Angelastro JM, Canoll PD, Kuo J, et al: Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5. Oncogene. 25:907–916. 2006.
11	Monaco SE, Angelastro JM, Szabolcs M and Greene LA: The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines. Int J Cancer. 120:1883–1890. 2007.
12	Dluzen D, Li G, Tacelosky D, Moreau M and Liu DX: BCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in a cell type-dependent manner. J Biol Chem. 286:7705–7713. 2011.
13	Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ and Green DR: The BCL-2 family reunion. Mol Cell. 37:299–310. 2010.
14	Harris MH and Thompson CB: The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ. 7:1182–1191. 2000.
15	Cobbs CS, Soroceanu L, Denham S, Zhang W and Kraus MH: Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res. 68:724–730. 2008.
16	Barami K: Oncomodulatory mechanisms of human cytomegalovirus in gliomas. J Clin Neurosci. 17:819–823. 2010.
17	Michaelis M, Kotchetkov R, Vogel JU, Doerr HW and Cinatl J Jr: Cytomegalovirus infection blocks apoptosis in cancer cells. Cell Mol Life Sci. 61:1307–1316. 2004.
18	Ranganathan P, Clark PA, Kuo JS, Salamat MS and Kalejta RF: Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples. J Virol. 86:854–864. 2012.
19	Xuan B, Qian Z, Torigoi E and Yu D: Human cytomegalovirus protein pUL38 induces ATF4 expression, inhibits persistent JNK phosphorylation, and suppresses endoplasmic reticulum stress-induced cell death. J Virol. 83:3463–3474. 2009.
20	Benedict CA, Norris PS and Ware CF: To kill or be killed: viral evasion of apoptosis. Nat Immunol. 3:1013–1018. 2002.
21	Poland SD, Costello P, Dekaban GA and Rice GP: Cytomegalovirus in the brain: in vitro infection of human brain-derived cells. J Infect Dis. 162:1252–1262. 1990.
22	Ogura T, Tanaka J, Kamiya S, Sato H, Ogura H and Hatano M: Human cytomegalovirus persistent infection in a human central nervous system cell line: production of a variant virus with different growth characteristics. J Gen Virol. 67:2605–2616. 1986.
23	Cobbs CS, Harkins L, Samanta M, et al: Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 62:3347–3350. 2002.
24	Sadanari H, Yamada R, Ohnishi K, Matsubara K and Tanaka J: SUMO-1 modification of the major immediate-early (IE) 1 and 2 proteins of human cytomegalovirus is regulated by different mechanisms and modulates the intracellular localization of the IE1, but not IE2, protein. Arch Virol. 150:1763–1782. 2005.
25	Zhu H, Shen Y and Shenk T: Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol. 69:7960–7970. 1995.
26	Schwartz R, Helmich B and Spector DH: CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter. J Virol. 70:6955–6966. 1996.
27	Pu P, Kang C, Zhang Z, Liu X and Jiang H: Downregulation of PIK3CB by siRNA suppresses malignant glioma cell growth in vitro and in vivo. Technol Cancer Res Treat. 5:271–280. 2006.
28	Teng MW, Bolovan-Fritts C, Dar RD, et al: An endogenous accelerator for viral gene expression confers a fitness advantage. Cell. 151:1569–1580. 2012.
29	Bai Z, Li L, Wang B, et al: Effect of inducible expressed human cytomegalovirus immediate early 86 protein on cell apoptosis. Biosci Biotechnol Biochem. 73:1268–1273. 2009.
30	Hu M, Wang B, Qian D, et al: Interference with ATF5 function enhances the sensitivity of human pancreatic cancer cells to paclitaxel-induced apoptosis. Anticancer Res. 32:4385–4394. 2012.
31	Chen A, Qian D, Wang B, et al: ATF5 is overexpressed in epithelial ovarian carcinomas and interference with its function increases apoptosis through the downregulation of Bcl-2 in SKOV-3 cells. Int J Gynecol Pathol. 31:532–537. 2012.
32	Augelastro JM, Canoll PD, Kuo J, et al: Selective destruction of glioblastoma cells by interference with the activityor expression of ATF5. Oncogene. 25:907–916. 2006.